Stimulant treatment of ADHD and cigarette smoking: A meta-analysis

Pediatrics

Volumn 133, Issue 6, 2014, Pages 1070-1080

  Schoenfelder, Erin N ^a   Faraone, Stephen V ^b   Kollins, Scott H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

ADHD; Cigarette smoking; Metaanalysis; Psychostimulant medication

Indexed keywords

PSYCHOSTIMULANT AGENT;

ACADEMIC FAILURE; ADOLESCENT SMOKING; ATTENTION DEFICIT DISORDER; CHILD PARENT RELATION; DISEASE ASSOCIATION; DRUG EFFECT; FAMILY CONFLICT; HUMAN; META ANALYSIS; ONSET AGE; OUTCOME ASSESSMENT; PEER PRESSURE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE;

ADHD; CIGARETTE SMOKING; META-ANALYSIS; PSYCHOSTIMULANT MEDICATION;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; RISK; SMOKING; STATISTICS AS TOPIC; TOBACCO USE DISORDER; UNITED STATES; YOUNG ADULT;

EID: 84901854048     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0179     Document Type: Review

References (83)

1. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-864 doi:10.1001/archpedi.161.9.857 (Pubitemid 47360887)
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164 (6):942-948 doi:10.1176/appi.ajp.164.6.942 (Pubitemid 46972911)
3. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723 doi:10.1176/appi.ajp.163.4.716 (Pubitemid 44464584)
4. Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002;63(suppl 12):10-15 (Pubitemid 36025582)
5. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328-341
6. McClernon FJ, Kollins SH. ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci. 2008;1141:131 -147
7. Molina BSG, Pelham WEJ Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112(3):497-507 (Pubitemid 36959375)
8. Rohde P, Kahler CW, Lewinsohn PM, Brown RA. Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine Tob Res. 2004;6(1): 119-132 doi:10.1080/ 14622200310001656948 (Pubitemid 38372482)
9. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328-341
10. Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/ hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41(7):799-805 doi:10.1097/00004583-200207000-00011 (Pubitemid 38338095)
11. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings. Am J Addict. 1997;6(3):205-217 (Pubitemid 27356003)
12. Molina BS, Hinshaw SP, Eugene Arnold L, et al Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013;52(3):250-263
13. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36(1):37-44 doi:10.1097/00004583-199701000- 00015 (Pubitemid 27024226)
14. Biederman J, Monuteaux MC, Mick E, et al. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry. 2006;59(3):258-264 doi:10.1016/j.biopsych.2005.07.009 (Pubitemid 43208973)
15. Biederman J, Petty CR, Hammerness P, Batchelder H, Faraone SV. Cigarette smoking as a risk factor for other substance misuse: 10-year study of individuals with and without attention-deficit hyperactivity disorder. Br J Psychiatry. 2012;201(3):207-214
16. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse. 1995; 7(3):373-378 (Pubitemid 26032582)
17. Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(44):889-894
18. Humfleet GL, Prochaska JJ, Mengis M, et al. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine Tob Res. 2005;7(3): 453-460 doi:10.1080/14622200500125310 (Pubitemid 41418718)
19. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and productivity Losses-United states, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57(45):1226-1228
20. De Biasi M, Dani JA. Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci. 2011;34:105-130
21. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56(suppl 1):3-8
22. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001;49(3):258-267 (Pubitemid 32178435)
23. Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 2010;210(4):453-469
24. Levin ED, Conners CK, Sparrow E, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 1996;123(1):55-63
25. Bain EE, Robieson W, Pritchett Y, et al A randomized, double-blind, placebo-controlled phase 2 study of alpha4beta2 agonist ABT-894 in adults with ADHD. Neuropsychopharmacology. 2013;38(3):405-413
26. Wilens TE, Biederman J, Spencer TJ, et al. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1999;156(12):1931- 1937
27. Bain EE, Apostol G, Sangal RB, et al A randomized pilot study of the efficacy and safety of ABT-089, a novel alpha4beta2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2012;73(6):783-789
28. Wilens TE, Gault LM, Childress A, et al Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry. 2011;50(1):73-84
29. Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA. ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry. 2006;59(11):1065-1070 doi:10.1016/j.biopsych.2005.10.029 (Pubitemid 43849655)
30. Heishma SJ, Taylor RC, Henningfield JE. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol. 1994;2(4):345
31. Conners CK, Levin ED, Sparrow E, et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull. 1996;32(1):67-73 (Pubitemid 26176204)
32. Levin ED, Conners CK, Silva D, Canu W, March J. Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol. 2001;9(1):83-90 (Pubitemid 32852217)
33. Glass K, Flory K. Why does ADHD confer risk for cigarette smoking? A review of psychosocial mechanisms. Clin Child Fam Psychol Rev. 2010;13(3):291-313
34. Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE. Methylphenidate increases cigarette smoking. Psychopharmacology (Berl). 2005;181(4):781-789 doi:10.1007/s00213-005-0021-8 (Pubitemid 41400764)
35. Stoops WW, Poole MM, Vansickel AR, Hays KA, Glaser PE, Rush CR. Methylphenidate increases choice of cigarettes over money. Nicotine Tob Res. 2011;13(1):29-33
36. Vansickel AR, Stoops WW, Glaser PE, Rush CR. A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology (Berl). 2007;193(3): 305-313 doi:10.1007/s00213-007-0786-z (Pubitemid 47063509)
37. Vansickel AR, Poole MM, Stoops WW, et al Stimulant-induced changes in smoking and caloric intake: influence of rate of onset. Pharmacol Biochem Behav. 2009;92(4): 597-602
38. Sigmon SC, Tidey JW, Badger GJ, Higgins ST. Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money. Psychopharmacology (Berl). 2003;167(4):393-402 doi:10.1007/s00213- 003-1416-z (Pubitemid 36754241)
39. Tidey JW, O'Neill SC, Higgins ST. d-amphetamine increases choice of cigarette smoking over monetary reinforcement. Psychopharmacology (Berl). 2000;153(1):85-92 (Pubitemid 32127906)
40. Kollins SH, Schoenfelder E, English JS, McClernon FJ, Dew RE, Lane SD. Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention de fi cit hyperactivity disorder (ADHD). Exp Clin Psychopharmacol. 2013;21(5):375-384
41. Kollins SH, English JS, Itchon-Ramos N, et al. A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD. J Atten Disord. 2014;18 (2):158-168
42. Winhusen TM, Somoza EC, Brigham GS, et al Impact of attention-deficit/ hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010;71 (12):1680-1688
43. Golubchik P, Sever J, Weizman A. Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders. Clin Neuropharmacol. 2009;32(5):239-242
44. Hammerness P, Joshi G, Doyle R, et al Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, longterm, open-label study of extended-release methylphenidate. J Pediatr. 2013;162(1):22-27
45. Humphreys KL, Eng T, Lee SS. Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry. 2013;70 (7):740-749
46. Colby SM, Tiffany ST, Shiffman S, Niaura RS. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend. 2000;59(suppl 1):S83-S95
47. Gervais A, O'Loughlin J, Meshefedjian G, Bancej C, Tremblay M. Milestones in the natural course of onset of cigarette use among adolescents. CMAJ. 2006;175(3):255-261 (Pubitemid 44230824)
48. Selya AS, Wakschlag LS, Dierker LC, Rose JS, Hedeker D, Mermelstein RJ. Exploring alternate processes contributing to the association between maternal smoking and the smoking behavior among young adult offspring. Nicotine Tob Res. 2013;15 (11):1873-1882
49. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottowa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://ohri.ca/programs/clinica-epidemiology/ oxford.htm. Accessed February 22, 2014
50. Review manager (RevMan). [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
51. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315 (7109):629 -634
52. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry. 2008;165 (5):597-603 (Pubitemid 351705336)
53. Wilens TE, Adamson J, Monuteaux MC, et al Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med. 2008;162(10):916-921
54. Winters KC, Lee S, Botzet A, Fahnhorst T, Realmuto GM, August GJ. A prospective examination of the association of stimulant medication history and drug use outcomes among community samples of ADHD youths. J Child Adolesc Subst Abuse. 2011; 20(4):314-329 doi:10.1080/1067828X.2011.598834
55. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998;31(6):533 -544
56. Upadhyaya HP, Rose K, Wang W, et al. Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol. 2005;15(5):799 -809 doi:10.1089/cap.2005.15.799
57. Huss M, Poustka F, Lehmkuhl G, Lehmkuhl U. No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study. J Neural Transm. 2008;115(2): 335-339
58. Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics. 2003;111(1): 97-109 (Pubitemid 36071038)
59. Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry. 2003;64(suppl 11):9-13 (Pubitemid 37169643)
60. Flory K, Malone PS, Lamis DA. Childhood ADHD symptoms and risk for cigarette smoking during adolescence: School adjustment as a potential mediator. Psychol Addict Behav. 2011;25(2):320-329
61. Molina BSG, Marshal MP, Pelham WEJ Jr, Wirth RJ. Coping skills and parent support mediate the association between childhood attention-deficit/ hyperactivity disorder and adolescent cigarette use. J Pediatr Psychol. 2005;30(4):345-357 doi:10.1093/jpepsy/jsi029 (Pubitemid 40629161)
62. Flory K, Malone PS, Lamis DA. Childhood ADHD symptoms and risk for cigarette smoking during adolescence: school adjustment as a potential mediator. Psychol Addict Behav. 2011;25(2):320-329
63. Burke JD, Loeber R, Lahey BB. Which aspects of ADHD are associated with tobacco use in early adolescence? J Child Psychol Psychiatry. 2001;42(4):493-502 (Pubitemid 32509771)
64. Walther CAP, Cheong J, Molina BSG, et al. Substance use and delinquency among adolescents with childhood ADHD: the protective role of parenting. Psychol Addict Behav. 2012;26(3):585-598 doi:10.1037/a0026818
65. Chassin L, Presson CC, Sherman SJ, Edwards DA. The natural history of cigarette smoking: predicting young-adult smoking outcomes from adolescent smoking patterns. Health Psychol. 1990;9(6):701-716
66. Larzelere RE, Kuhn BR, Johnson B. The intervention selection bias: an underrecognized confound in intervention research. Psychol Bull. 2004;130(2):289-303 doi:10.1037/0033-2909.130.2.289 (Pubitemid 38317812)
67. August GJ, Winters KC, Realmuto GM, Fahnhorst T, Botzet A, Lee S. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry. 2006;45(7):824-832 doi:10.1097/01.chi.0000219831.16226.f8 (Pubitemid 43932909)
68. August GJ, Realmuto GM, Crosby RD, MacDonald AW III. Community-based multiple-gate screening of children at risk for conduct disorder. J Abnorm Child Psychol. 1995;23(4):521-544
69. Hinshaw SP, Lee SS. Conduct and oppositional de fiant disorders. Child Psychopathol. 2003;2:144-198
70. Lahey BB, Applegate B, Waldman ID, Loft JD, Hankin BL, Rick J. The structure of child and adolescent psychopathology: generating new hypotheses. J Abnorm Psychol. 2004;113(3):358 -385 doi:10.1037/0021-843X. 113.3.358
71. Levy F. Synaptic gating and ADHD: a biological theory of comorbidity of ADHD and anxiety. Neuropsychopharmacology. 2004; 29(9):1589-1596 (Pubitemid 39150100)
72. Bussing R, Zima BT, Mason D, Hou W, Garvan CW, Forness S. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15(1):78-87 doi:10.1089/cap.2005.15.78 (Pubitemid 40365917)
73. Molina BS, Hinshaw SP, Swanson JM, et al The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484-500
74. Palli SR, Kamble PS, Chen H, Aparasu RR. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012;22(2):139-148
75. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922-928 doi:10.1097/00004583-200108000- 00014 (Pubitemid 32667075)
76. Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med. 2010;122(1):184-191
77. Ercan SE, Kose S, Kutlu A, Akyol O, Durak S, Aydin C. Treatment duration is associated with functioning and prognosis in children with attention deficit hyperactivity disorder. Bulletin of Clinical Psychopharmacology. 2012;22(2):148-160
78. Faraone SV, Biederman J, Wilens TE, Adamson J. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med. 2007;37(12):1743-1752 doi:10.1017/S0033291707000335 (Pubitemid 350100430)
79. Groenman AP, Oosterlaan J, Rommelse NN, et al. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. Br J Psychiatry. 2013;203(2):112-119
80. Monuteaux MC, Spencer TJ, Faraone SV, Wilson AM, Biederman J. A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2007;68(7):1094-1101 (Pubitemid 47340332)
81. Whalen CK, Jamner LD, Henker B, Gehricke JG, King PS. Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD? Psychol Addict Behav. 2003;17(4):332-335 doi:10.1037/0893-164X.17.4.332 (Pubitemid 37509922)
82. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attentiondeficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 1999;104(2). Available at: www.pediatrics.org/cgi/content/full/104/ 2/e20
83. Loney J, Kramer JR, Salisbury H. Medicated versus unmedicated ADHD children: adult involvement with legal and illegal drugs. In: Jensen PS, ed. Attention Deficit Hyperactivity Disorder: State of the Science-Best Practices. Kingston, NJ: Civic Research Institute; 2002:17-1-17-16